Document Detail


Sister-chromatid exchanges in newborns after normal and progesterone-treated pregnancies.
MedLine Citation:
PMID:  3600694     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Two groups of newborns were selected for SCE analyses, one consisting of infants born after progesterone-treatment during pregnancy (PTP) and a control group. A slight, but statistically significant difference in the number of SCEs was found: in the control group 5.55 +/- 0.62, and in the PTP group 7.99 +/- 0.88. This effect also proved to be true in an in vitro system, where various concentrations of progesterone were tested. The authors offer two possible explanations: one involving the biochemical pathways of progesterone and the influence on the level of excretory products; the other involving a direct relationship between progesterone and DNA.
Authors:
B Lukić; N Barjaktarović
Related Documents :
7936514 - Serum progesterone for the exclusion of early pregnancy in women at risk for recurrent ...
15695314 - What is the 'ideal' duration of progesterone supplementation before the transfer of cry...
21278504 - Labor and fetal heart rate decelerations: relation to fetal metabolic acidosis.
2271724 - Effects of progesterone antagonist, lilopristone (zk 98.734), on induction of menstruat...
21726344 - Anti-hy responses in pregnancy disorders.
11191874 - Effects of lactation length and weaning-to-service interval on subsequent farrowing rat...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Mutation research     Volume:  191     ISSN:  0027-5107     ISO Abbreviation:  Mutat. Res.     Publication Date:  1987 Jun 
Date Detail:
Created Date:  1987-07-29     Completed Date:  1987-07-29     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0400763     Medline TA:  Mutat Res     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  121-4     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
DNA Damage*
Female
Humans
Infant, Newborn
Lymphocytes / ultrastructure
Maternal-Fetal Exchange
Pancuronium / administration & dosage,  analogs & derivatives*,  pharmacology
Pregnancy
Pregnancy Complications / drug therapy
Progesterone / administration & dosage,  metabolism,  pharmacology*
Sister Chromatid Exchange / drug effects*
Chemical
Reg. No./Substance:
0/Pancuronium; 43021-45-0/dacuronium; 57-83-0/Progesterone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Complementation studies in cells from patients affected by trichothiodystrophy with normal or enhanc...
Next Document:  Chromosomal aberrations in cultured human lymphocytes treated with aldicarb, a carbamate pesticide.